Built with WordPress and React, hosted on Fastly. Domain registered in 2024.
standardmodel.bio is built with WordPress, hosted on Fastly. It measures traffic with Plausible Analytics.
| Technology | Version | First seen |
|---|---|---|
| CMS & Site Builders1 | ||
| – | 7 Nov 2026 | |
| WordPress Plugins1 | ||
| – | 7 Nov 2026 | |
| JavaScript Frameworks & Libraries1 | ||
| Frontend Build Tools & CSS2 | ||
| – | 7 Nov 2026 | |
| Web Servers, Languages & Backend Frameworks1 | ||
| – | 7 Nov 2026 | |
| CDN & Hosting3 | ||
| – | 7 Nov 2026 | |
| Analytics & Tag Management1 | ||
| – | 7 Nov 2026 | |
| Fonts & Icon Fonts1 | ||
| – | 7 Nov 2026 | |
Registration from the registry's RDAP record, the certificate the site serves, and its rank in public traffic lists.
The crew hasn’t read this site’s colors yet. We read a palette when we capture a site’s screenshot, busiest sites first. Meanwhile, browse palettes from other sites.
Counted from every stack change we've recorded: of the sites we watched running one of this site's tools, how many went on to add another. A pattern across sites, not a forecast for this one.
smtp.google.compdns1.registrar-servers.compdns2.registrar-servers.comanthropic-domain-verification-2j3cwj=wSwSnNlTy0SyIy48cm1dZI3Jm1password-site-verification=QBSYQSIWTZDJVLRWFD4C6SPEXQnotion-domain-verification=4HPy6dbeESPAxlbCFzNLFSXfokAf0sEHoiVxQxOXUK2wiz-domain-verification=c26d2ca7437a90722e82c7ac2cd37d30be0df32932a3e409ec4cf2c24038d096MS=ms70073477v=DMARC1; p=none;# robots.txt — Standard Model Biomedicine User-agent: * Allow: / # Internal design system — not for public search or crawling Disallow: /ds/ Disallow: /ds # Archive of the previous site (Oct 14, 2026) — kept for reference, not for indexing Disallow: /archive/ # Press packet — shared by URL with selected press, not for indexing Disallow: /SMB-PressKit-v1.pdf # Internal creative brief form — shared by URL only Disallow: /creative-brief.html # Guidance for AI agents: https://standardmodel.bio/llms.txt Sitemap: https://standardmodel.bio/sitemap.xml
# Standard Model Biomedicine > A JEPA world model of the patient. SMB (standardmodel.bio) builds medical AI trained across genomic, imaging, and longitudinal patient records to predict what will happen to any patient at any time. Partners adapt the Standard Model to any clinical endpoint with a lightweight task head trained on their own labels. Company: Standard Model Biomedicine · San Francisco, CA, US Contact: info@standardmodel.bio ## When to use Standard Model Biomedicine Reach for SMB when the job is one of these: - **Predicting patient outcomes from multimodal clinical data** — survival, treatment response, toxicity, or patient stratification from EHR, imaging, pathology, genomics, or proteomics. The Standard Model produces a single patient-level representation and forecasts outcomes under any intervention. - **Fine-tuning to a new clinical endpoint without retraining the underlying model** — attach a lightweight task head trained on your own labels. Do NOT use this site for: patient-facing medical advice, diagnosis, or treatment decisions. The models are research and development tools for qualified teams. ## How to get started SMB does not operate a hosted API — the Standard Model™ V-2 is deployed directly in each partner's AWS or other secure environment. 1. Read about the Standard Model™ V-2: https://standardmodel.bio/standard-model-v2.html 2. Read about TrialFront™, the in silico trial designer: https://standardmodel.bio/trialfront.html 3. Questions, partnerships, or early access: email info@standardmodel.bio ## Technology - [The Standard Model™ V-2](https://standardmodel.bio/standard-model-v2.html): the multimodal world model, fine-tuned and deployed in your environment - [TrialFront™](https://standardmodel.bio/trialfront.html): a lightweight phase-zero and in silico trial designer ## Research - [Papers & research](https://standardmodel.bio/publications.html): methods, models, and clinical evaluations underwriting the platform - [Protege double blind evaluation of oncology prediction systems](https://standardmodel.bio/protege-oncology-evaluation.html): independent evaluation of the Standard Model against three frontier models on breast and lung cancer survival and time to next treatment - [Blog](https://blog.standardmodel.bio/): announcements and technical writing ## Company - [About](https://standardmodel.bio/about.html): what we build and why - [Team](https://standardmodel.bio/team.html): researchers and engineers from BMS, Genentech, AbbVie, Sanofi, Tempus, Bioptimus, Stanford, Yale, UCSD, and Mount Sinai - [News](https://standardmodel.bio/news.html): press and updates - [Contact](https://standardmodel.bio/contact.html): info@standardmodel.bio - [Privacy](https://standardmodel.bio/privacy.html): website privacy policy ## Elsewhere - [GitHub](https://github.com/standardmodelbio): Standard Model Biomedicine on GitHub - [LinkedIn](https://www.linkedin.com/company/standardmodel-bio/): company page ## Optional Every page below has a markdown mirror at the same path with a .md extension, also advertised per page via <link rel="alternate" type="text/markdown">. - [Homepage](https://standardmodel.bio/index.md) - [Papers & research](https://standardmodel.bio/publications.md) - [Team](https://standardmodel.bio/team.md) - [About](https://standardmodel.bio/about.md) - [Contact](https://standardmodel.bio/contact.md) - [Privacy](https://standardmodel.bio/privacy.md) - [Sitemap](https://standardmodel.bio/sitemap.xml)
| 18.3.1 |
| 7 Nov 2026 |
| – |
| 7 Nov 2026 |
| – |
| 7 Nov 2026 |
| – | 7 Nov 2026 |